ID: ALA5173238

Max Phase: Preclinical

Molecular Formula: C28H30N6O

Molecular Weight: 466.59

Associated Items:

Representations

Canonical SMILES:  C1=CC2c3ccccc3NC2C(CNCCOCCNCc2nccc3c2[nH]c2ccccc23)=N1

Standard InChI:  InChI=1S/C28H30N6O/c1-3-7-23-19(5-1)21-9-11-31-25(27(21)33-23)17-29-13-15-35-16-14-30-18-26-28-22(10-12-32-26)20-6-2-4-8-24(20)34-28/h1-12,21,27,29-30,33-34H,13-18H2

Standard InChI Key:  NKBDEYRYICLVHS-UHFFFAOYSA-N

Associated Targets(Human)

NCI-H1299 3248 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 466.59Molecular Weight (Monoisotopic): 466.2481AlogP: 3.96#Rotatable Bonds: 10
Polar Surface Area: 86.36Molecular Species: BASEHBA: 6HBD: 4
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.95CX Basic pKa: 8.50CX LogP: 2.45CX LogD: 0.73
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.27Np Likeness Score: -0.02

References

1. Aaghaz S, Sharma K, Jain R, Kamal A..  (2021)  β-Carbolines as potential anticancer agents.,  216  [PMID:33684825] [10.1016/j.ejmech.2021.113321]

Source